Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04611139
Title Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors HonorHealth Research Institute

endometrioid ovary carcinoma

small-cell carcinoma of the ovary of hypercalcemic type

endometrial adenocarcinoma

ovarian clear cell carcinoma


Pembrolizumab + Seclidemstat

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
*Shaded cells indicate that there was no data available from for the field